1)CETP geneCETP基因
1.Conclusion CETP gene TaqⅠ polymorphism is closely related to the risk of T2DM and the H+H-genotype may serve as a genetic risk factor of T2DM among Uygur people.方法依据病例对照设计方法,采用全自动生化分析仪等技术测地尔族体内脂质谱;应用聚合酶链反应-限制性内切酶长度多态性(PCR-RFLP)方法,对维吾尔族的53例T2DM患者、53例糖耐量异常患者和106名糖耐量正常者的CETP基因TaqⅠ酶切多态性进行比较分析。
英文短句/例句
1.Association of gene polymorphism of cholesteryl ester transfer protein with type 2 diabetesCETP基因多态性与维吾尔族2型糖尿病关系
2.Correlation between CETP and UCP2 Genes and Natural Longevity in Xinjiang Hetian Uygur Population;UCP2及CETP基因与新疆和田地区维吾尔族自然长寿的关联研究
3.The Associations between Uygur, Han APOA5, APOB, CETP Gene and Lipids of Coronary Heart Disease with Diabetes维吾尔族、汉族APOA5、APOB、CETP基因与冠心病合并糖尿病血脂的研究
4.Association of LPL、CETP and ApoA5 Gene Polymorphism with Type 2 Diabetes of UygurLPL、CETP、ApoA5基因多态性与维吾尔族2型糖尿病的关联研究
5.The Interaction between CETP-TaqIB and ApoE Polymorphism and It's Relation to CHD and Stroke;CETP-TaqIB多态性及ApoE多态性与心脑血管疾病
6.The Synthesis and Activity Evaluation of Novel CETP Inhibitors;新型CETP抑制剂的化学合成及其活性评价
7.The Synthesis and Activity Evaluation of Novel Small-molecule CETP Inhibitors新型CETP小分子抑制剂的合成及活性评价
8.The Relationship between Cholesteryl Ester Transfer Protein and Type 2 Diabetic Macroangiopathy and the Effect of Atorvastatin Treatment;CETP与2型糖尿病大血管病变的关系及阿托伐他汀治疗的影响
9.The Serum CETP Level and the D442G Mutation of Cholesteryl Ester Transfer Protein Gene in Patients with Coronary Heart Disease冠心病患者血清CETP水平及其D442G突变的相关性研究
10.extinguisher loci消失基因座,绝灭基因座
11.Of, relating to, produced by, or being genes or a gene.基因的基因的,与基因有关的,基因产生的
12.Genes are described as DOMINANT or RECESSIVE.基因分为显性基因和隐性基因。
13.hypomorphic allele次等位因素对偶基因
14.Studies on Polymorphism of Prolactin Receptor Gene and Follicle-Stimulating Hormone Beta Subunit Gene in Swine;猪PRLR基因和FSHβ亚基基因多态性研究
15.Research on Hte Microarray Based Gene Mining Algorithm;基于基因表达谱的基因挖掘算法研究
16.Human Genome Project,Post-genome Research and Gene Medicine --New Century of Diagnosis,Pharmaceutics and Therapy with Gene Technique;人类基因组计划、后基因组研究与基因医学——基因诊断、基因制药与基因治疗的新世纪
17.Genetic material produced by gene-splicing.重组基因材料基因分割而产生的基因材料
18.Gene distribution was out of balance. Dominant genes were more than recessive ones.基因的分布是不对称的,显性基因多于隐性基因。
相关短句/例句
L296Q polymorphism in the CETP geneCETP基因L296Q多态性
3)CETP inhibitorCETP抑制剂
1.Therefore,CETP inhibitor could be expected to raise plasma HDL cholesterol(HDLc) levels,lower LDL cholesterol(LDLc) levels,and provide a potential therapeutic benefit for patient with heart artery disease.因此人们认为CETP抑制剂可以提高血浆中高密度脂蛋白胆固醇(HDLc)水平,降低低密度脂蛋白胆固醇(LDLc)水平,从而为心血管疾病提供了一种潜在的治疗方法。
4)gene[英][d?i:n][美][d?in]基因
1.Study of the Preparation and the Characteristics of pRc/CMV-BChE Gene-chitosan nanoparticles ①;丁酰胆碱酯酶基因-壳聚糖纳米粒初步研究
2.Correlation between traditional Chinese medicine syndromes in primary immunoglobulin A nephropathy and A267G in 5'-untranslated region within exonal of megsin gene;Megsin基因E1-5’UTR区A267G与免疫球蛋白A型肾病阴虚证的相关性
3.Study on gene chip of leiomyoma of uterus;子宫肌瘤基因芯片的研究
5)Genes基因
1.Study on Apoptosis of Human Leukemia Cells and Its Related Genes Regulation Induced by ~(235) U;浓缩铀诱发细胞凋亡的形态及基因调控
2.Screening of lymphatic metastasis-associated genes in esophageal squamous cell carcinoma;食管癌淋巴结转移相关基因筛选的研究
3.Study on the Genotyping of Aminoglycoside Modifying Enzymes Genes from Pan-drug Resistant Acinetobacter Baumannii.;泛耐药鲍曼不动杆菌氨基糖苷类修饰酶基因研究
6)Polymorphism[英][,p?li'm?:fiz?m][美][,pɑl?'m?rf?zm?]基因
1.The Study on Apolipoprotein E Gene Polymorphism Characteristics of Cerebral Infarction and Intracerebral Hemorrhage;脑梗死与脑出血apoE-基因多态性特点研究
2.The Relations of Gene Polymorphisms of eNOS and FⅦ with Coronary Heart Disease in Henan Han Population;河南汉族人群一氧化氮合酶和凝血因子Ⅶ基因多态性与冠心病相关性分析
3.Methods:Polymorphism of the 677th site C/T of MTHFR gene and the 66th site A/G of MTRR gene were detected by polymerase chain reaction-restrction fragment length polymorphism in disease group(n=64) and normal controls(n=104).目的:研究同型半胱氨酸相关酶中亚甲基四氢叶酸还原酶(MTHFR)及蛋氨酸合成酶还原酶(MTRR)基因的多态性与先天神经管缺陷的关系。
延伸阅读
[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。